EZH2 in Bladder Cancer, a Promising Therapeutic Target

Bladder Cancer (BC) represents a current clinical and social challenge. The recent studies aimed to describe the genomic landscape of BC have underscored the relevance of epigenetic alterations in the pathogenesis of these tumors. Among the epigenetic alterations, histone modifications occupied a ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Fernández, Mónica, Rubio, Carolina, Segovia, Cristina, López-Calderón, Fernando F., Dueñas, Marta, Paramio, Jesús M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661858/
https://www.ncbi.nlm.nih.gov/pubmed/26580594
http://dx.doi.org/10.3390/ijms161126000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661858/
https://www.ncbi.nlm.nih.gov/pubmed/26580594
http://dx.doi.org/10.3390/ijms161126000

Ejemplares similares